This suggests that GLP1Ra treatment which induced at least an 8% weight loss showed significant bone loss, and the null findings in this exploratory post hoc analysis may, in part, reflect the modest weight loss achieved over a relatively short intervention period, particularly when compared with outcomes observed in larger, longer-term trials
Gastrointestinal side effects For those who experience side effects, most people will feel them along the digestive tract
Users of oral semaglutide formulations and sublingual semaglutide bypass injection site reactions entirely, which represents one advantage of non-injectable delivery routes
The American journal of gastroenterology 105 , 13381345, doi:10.1038/ajg.2009.719 (2010)
However, like many beneficial compounds in the body, its levels decline significantly with age
The answer is based on the plan you are in and your age